Skip to content

Study to assess the usefulness of a new drug, Dexmedetomidine, for sedation of patients during insertion of a tube in the wind pipe using endoscopy before anaesthesia

To study the effectiveness of â??Dexmedetomidineâ?? for sedation in elective awake fibre-optic intubation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/08/002858
Enrollment
80
Registered
2012-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients requiring awake fibreoptic intubation prior to induction of general anaesthesia

Interventions

Intervention1: Dexmedetomidine: single intravenous loading dose of Dexmedetomidine 1.0mcg/kg over 10 mins Control Intervention1: Placebo: intravenous 0.9% sodium chloride for injection in volume simil

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients undergoing major head and neck surgeries scheduled for an elective nasal awake fibreoptic intubation due to an anticipated difficult airway 2)ASA Physical Status I-II.

Exclusion criteria

Exclusion criteria: 1)Pregnant or lactating females 2)Use of an α-2-adrenoreceptor agonist or antagonist within 14 days 3)Use of an opiod administered orally or intravenously within 1 hr or intramuscularly within 4 hrs 4)Presence of increased intracranial pressure or CSF leak 5)Acute alcohol intoxication 6)Uncontrolled seizure disorder 7)History of acute unstable angina 8)Laboratory in acute MI within past 6wks 9)Heart rate 50 beats per minute 10)Systolic blood pressure 90mmhg 11)Complete heart block unless patient had a pacemaker 12)Liver transaminase level 2 times the upper normal limit.

Design outcomes

Primary

MeasureTime frame
1)Ease of intubation:(acceptable score 3 to 6; not acceptable 6): median score and no. of patients 2)Percentage of patients requiring Midazolam for rescue sedation to achieve or maintain Ramsay Sedation Scale â?¥2 throughout the study. 3)Patient tolerance of procedure (no. of patients with a tolerance score of 1 or 2) 4)Patient cooperation (no. of patients with a score of 1) Timepoint: Till completion of fibreoptic intubation and induction of general anaesthesia

Secondary

MeasureTime frame
1)Mean dose of Midazolam required and number of patients in each group requiring resuce midazolam 2)Haemodynamic instability 3)Anaesthesiologistâ??s assessment of ease of patient care (either easy or not easy) 4)Recall of anxiety, pain and the procedure itself during the AFOI.Timepoint: upto 24 hours after the procedure

Countries

India

Contacts

Public ContactJV Divatia

Tata Memorial Hopsital

ckd7582@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026